Nkarta Executives Buy Big in Zero‑Cost Options as Stock Rides Weekly Surge, Signaling Confidence in Future Biotech Milestones
Insider buying at Nkarta signals confidence in its biotech pipeline—President Mahmood Nadir and execs are staking options on a $2.74 peak, hinting at future upside.
2 minutes to read